Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhBMP-2 bone graft material exposure study in cementless hemiarthroplasty for elderly femoral neck fracture
ChiCTR2600133853Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Wenzhou Medical University
- Start
- Sep 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of dibotermin alfa in Neck Of Femur Fracture, osteoporosis and osteopenia (2 arms), sponsored by The First Affiliated Hospital of Wenzhou Medical University. Primary endpoint: Incidence of significant femoral stem subsidence at 3 months. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
dibotermin alfa
03
Conditions
Neck Of Femur Fractureosteoporosisosteopenia
Beyond the preview
Go deeper on ChiCTR2600133853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600133853.